Pharmaceutical company Sanofi is planning to reduce its workforce by cutting 99 jobs at its sites in Ghent and Diegem. The restructuring is part of a global initiative to modernize the organization and focus on becoming a global player in immunology. Sanofi employs around 1,600 people in Belgium, and the planned job cuts will affect 67 positions in Ghent and 32 at the head office in Diegem.
The company is shifting its focus towards developing new vaccines and drugs in immunology that can make a real difference to patients. Sanofi has twelve new medicines and vaccines in clinical development that show promise for treating immune-related diseases. As a result, some early-stage research activities in Ghent will be discontinued.
Sanofi is exploring all possible solutions for employees whose jobs may be affected by the restructuring. The company is committed to adapting its operations to meet the evolving needs of the healthcare industry and provide cutting-edge treatments for patients.